Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Medical Scientist II

Biomedical Science · Nepal · 2025-06-16

Processing Time
169 days
Decision Date
2025-06-16
Location
Florida
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research in biomedical science, specifically focusing on therapeutic interventions for diabetes and liver diseases. His work involves evaluating ER stress and its role in diabetic retinopathy to improve patient outcomes and reduce healthcare costs in the U.S.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses critical global health concerns like diabetes and liver disease, offering solutions to reduce U.S. healthcare costs.

2 Well-positioned to Advance the Endeavor Met

The petitioner is supported by a strong publication record, citations, and funding from prestigious institutions like the NIH.

3 Balance of Interests Met

The petitioner's ongoing contributions to public health and the medical community justify a waiver of the job offer requirement.

Why This Petition Was Approved

The petition was approved based on a robust record of 8 peer-reviewed journal articles, 8 conference abstracts, and 25 citations. The petitioner also demonstrated expertise through peer review for prestigious journals and secured research funding from the National Eye Institute, NIGMS, and the Department of Defense.

Request for Evidence (RFE)

Successfully Addressed

USCIS issued an RFE during the review process; the legal team provided a well-documented response addressing all concerns, leading to approval.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Reference Letters Dependent
Grants
Conference Presentations
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Tennessee 184 days 2022-10-04
The petitioner proposes to continue his research on the isolation and characterization of naturally sourced bioactive pharmacological compounds. This work focuses on developing new preventative and curative therapies for disorders such as diabetes mellitus, diabetic gastroparesis, and anxiety disorders.
View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Connecticut 428 days 2021-05-19
The petitioner proposes to continue his research in biology and biomedical informatics, specifically focusing on the expansion of biomedical ontologies and the study of regulated exocytosis. His work aims to address the health and economic burdens of neurodegenerative, immune, and inherited diseases, including the development of new avenues for diabetes drug design.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
676 days 2025-10-22
The petitioner proposes to advance mechanistic understanding and treatment strategies for diabetes, cardiovascular disease, and oral cancer. The work focuses on uncovering biochemical drivers of metabolic disorders and identifying biomarkers to support earlier diagnosis and improved patient outcomes.
View Case

Research Scientist

Biotechnology · Egypt

WeGreened EB-2 (NIW) approved
United Arab Emirates 607 days 2025-09-18
The petitioner proposes to continue her research in the United States focusing on therapeutic targets for diabetes and cardiometabolic diseases. Her work utilizes cannabinoids, terpenes, and natural compounds to study oxidative stress, inflammation, and mitochondrial dysfunction to reduce organ injury and improve treatment outcomes.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Nepal

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-06-16.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 169 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 9

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Nepal All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist